BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2013 related articles for article (PubMed ID: 25788514)

  • 1. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
    Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
    Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
    Blair JM; Richmond GE; Piddock LJ
    Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii.
    Leus IV; Weeks JW; Bonifay V; Smith L; Richardson S; Zgurskaya HI
    J Bacteriol; 2018 Jul; 200(13):. PubMed ID: 29661860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
    Alenazy R
    Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hydrophobic trap-the Achilles heel of RND efflux pumps.
    Aron Z; Opperman TJ
    Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
    Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RND efflux pumps: structural information translated into function and inhibition mechanisms.
    Ruggerone P; Murakami S; Pos KM; Vargiu AV
    Curr Top Med Chem; 2013; 13(24):3079-100. PubMed ID: 24200360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RND efflux pump and its interrelationship with quorum sensing system.
    Liang ZB; Chen YM; Chen Y; Cheng YY; Zhang LH
    Yi Chuan; 2016 Oct; 38(10):894-901. PubMed ID: 27806930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance.
    Colclough AL; Alav I; Whittle EE; Pugh HL; Darby EM; Legood SW; McNeil HE; Blair JM
    Future Microbiol; 2020 Jan; 15():143-157. PubMed ID: 32073314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrAB-TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanism.
    Jang S
    BMB Rep; 2023 Jun; 56(6):326-334. PubMed ID: 37254571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?
    Gil-Gil T; Laborda P; Ochoa-Sánchez LE; Martínez JL; Hernando-Amado S
    Expert Opin Drug Discov; 2023 Jun; 18(6):671-686. PubMed ID: 37199662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial efflux transporters' polyspecificity - a gift and a curse?
    Zgurskaya HI; Malloci G; Chandar B; Vargiu AV; Ruggerone P
    Curr Opin Microbiol; 2021 Jun; 61():115-123. PubMed ID: 33940284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
    Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV
    ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in Klebsiella pneumoniae.
    Lv L; Wan M; Wang C; Gao X; Yang Q; Partridge SR; Wang Y; Zong Z; Doi Y; Shen J; Jia P; Song Q; Zhang Q; Yang J; Huang X; Wang M; Liu JH
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis of Peptide-Based Antimicrobial Inhibition of a Resistance-Nodulation-Cell Division Multidrug Efflux Pump.
    Lyu M; Ayala JC; Chirakos I; Su CC; Shafer WM; Yu EW
    Microbiol Spectr; 2022 Oct; 10(5):e0299022. PubMed ID: 36121287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.